Navigation Links
Katherine A. High, M.D., elected to the American Academy of Arts and Sciences
Date:5/10/2011

221.10.254.64

Katherine A. High, M.D., a gene therapy expert at The Children's Hospital of Philadelphia, has been elected to the 2011 class of the American Academy of Arts and Sciences. The Academy is one of the nation's most prestigious honorary societies and is a leading center for independent policy research.

Dr. High joins a select group of scholars, scientists, writers, artists, civic, corporate and philanthropic leaders that includes Nobel laureates, Pulitzer Prize awardees, and winners of MacArthur Fellowships, Oscar Awards and Kennedy Center honors.

A hematologist, Dr. High is internationally recognized for her research on gene therapy, particularly in developing and conducting landmark clinical studies. She has been in the forefront of the effort to develop gene therapy for the inherited bleeding disorder hemophilia and continues to pursue this research. She directs the Center for Cellular and Molecular Therapeutics at Children's Hospital. In 2009, that center sponsored a clinical trial that produced dramatic improvements in children and young adults with Leber's congenital amaurosis, a congenital form of blindness.

Dr. High is a Howard Hughes Medical Institute Investigator and the William H. Bennett Professor of Pediatrics at the University of Pennsylvania School of Medicine. She also is a past president of the American Society of Gene Therapy.


'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert  

Page: 1

Related biology news :

1. Yuemeng Dai, M.D., Ph.D., ear, nose and throat specialist, receives Bill Potsic Basic Science Award
2. Stephen Maturo, M.D., ear, nose and throat specialist, receives Charles Ferguson Award
3. George W. Sledge, Jr., M.D., honored for international contributions to breast cancer research
4. Don Detmer, M.D., receives 2010 Morris F. Collen Award
5. AACR nomination of Harold E. Varmus, M.D., as director of the NCI
6. Gregory Downey, M.D., of National Jewish Health, honored for scientific accomplishments
7. Dr. Marilyn M. Li, M.D., FACMG, is the 2010 Luminex/ACMGF award recipient
8. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
9. Georgetown Universitys Howard J. Federoff, M.D., Ph.D. receives Bernard Sanberg Memorial Award
10. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
11. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Katherine A. High, M.D., elected to the American Academy of Arts and Sciences
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... cells — optogenetics — is key to exciting advances in the study and ... patterned light projected via free-space optics stimulates small, transparent organisms and excites neurons ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc announced ... client demand KbioBox developed a sophisticated “3 click” gene dditing off target analysis ... KBioBox’s new website, https://www.kbiobox.com/ and powered by the company’s proprietary ...
(Date:12/8/2016)... 8, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... developing and commercializing products to treat rare diseases where ... it will be hosting an Investor Webcast Event Friday, ... origins of innate defense regulators (IDRs) as a new ... mucositis and the recently announced and published Phase 2 ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selector™ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
Breaking Biology Technology: